导师简介--胡培

出生年月

1989年6月

单位

湖北医药学院生物医学工程学院/附属太和医院

所属学科

医学技术-医学检验

职称、职务

副教授，主管技师，硕士研究生导师

E-mail

skylinehp@163.com

联系方式（办公电话）

0719-8801867

研究方向

肿瘤的早期诊断与治疗

个人简介

胡培，男，1989年6月生，博士，副教授，硕士研究生导师。从事肿瘤的早期诊断与治疗方向的研究工作。

主持完成省科技厅、教育厅等科研项目9项，发表论文16篇，其中SCI收录论文12篇。

代表作如下：

Hu S, Li R, Gong D, Hu P, et al. Atf3-mediated metabolic reprogramming in hepatic macrophage orchestrates metabolic dysfunction-associated steatohepatitis. Sci Adv. 2024 Jul 26;10(30): eado3141.

Gu JX, Huang K, Zhao WL, Zheng XM, Wu YQ, Yan SR, Huang YG*, Hu P*. NCAPD2 augments the tumorigenesis and progression of human liver cancer via the PI3K-Akt-mTOR signaling pathway. Int J Mol Med. doi: 10.3892/ijmm.2024.54(4):84. Epub 2024 Aug 2.

Wang P, Tong K, Li Y, Li X, Zhang Y, Gu J, Lei P, Yan S*,Hu P*. The role and mechanism of HIF-1α-mediated glypican-3 secretion in hypoxia-induced tumor progression in hepatocellular carcinoma. Cellular Signalling. 2023 Dec 10;114:111007.

Tong K, Wang P, Li Y, Tong Y, Li X, Yan S*,Hu P*. Resveratrol Inhibits Hepatocellular Carcinoma Progression Through Regulating Exosome Secretion. Curr Med Chem. 2024;31(15):2107-2118.

Li X, Wu Y, Wang P, Li Y, Gu J, Zhang Y, Yan S*,Hu P*. LncRNA XXYLT1-AS2 promotes tumor progression via autophagy inhibition through ubiquitinated degradation of TFEB in hepatocellular carcinoma. 2024 Mar;26(3):698-708.

Tong Y, Tong K, Zhu Q, Wu Y, Yang Y, Zhang J,Hu P*, Yan S*. Cobalt Chloride Induced Apoptosis by Inhibiting GPC3 Expression via the HIF-1α/c-myc Axis  in HepG2 Cells.  Oncotargets  and Therapy 2019; 12:10663-10670.

Hu P, Ke C, Guo X, Ren P, Tong Y, Luo S, He Y, Wei Z, Cheng B, Li R, Luo J, Meng Z. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of  curcumin on hepatocellular carcinoma. Digestive and liver disease 2019, 51(1):120-126. Digestive and liver disease.